FindMyKOL
Clinical trialNCT05351502UnknownPhase 1Interventional

A Study to Assess the Safety and Efficacy of Nitric Oxide Injection Into Unresectable Solid Primary or Metastatic Tumors

SponsorBeyond Air Inc.Enrollment38Cancer
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a Phase 1, open-label, dose-escalation and dose-expansion study comprised of 2 parts: Phase 1a - a single treatment session, an evaluation period of 21±3 days, and safety and survival follow-up period of up to 12 weeks post-treatment, and Phase 1b - a single treatment session followed by PD-1 inhibitors treatment cycles, in PD-1 single agent progressors, to evaluate safety, overall response rate, duration of response, progression free survival, and overall survival follow-up until disease progression or death.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Israel
  • Soroka Medical Center

    Beersheba, Israel

  • Hadassah Ein-Karem

    Jerusalem, Israel

  • Sheba Medical Center

    Ramat Ef‘al, Israel

  • Sourasky Tel Aviv Medical Center

    Tel Aviv, Israel

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Nitric Oxide 25,000 ppmNitric Oxide 50,000 ppm
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
14 Aug 2022
Primary completion
31 Aug 2025
Completion
31 Aug 2025
Last update posted
13 Oct 2026
Registered enrollment
38
Registry id
NCT05351502
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.